Contineum Therapeutics, Inc. Class A Common Stock vs. Eli Lilly & Co.
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
$8.56 -35.99%
VS LLYEli Lilly & Co.
$1182.62 +0.28%
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CTNM | LLY | |
|---|---|---|
| Market Cap | $503.37 million | $1.05 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| CTNM | LLY | |
|---|---|---|
| Dividend Yield | — | 0.59% |
CTNM and LLY split the dividend factors evenly.
Risk & Sentiment
| CTNM | LLY | |
|---|---|---|
| Short Interest | 1.59% | 1.29% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: CTNM overview, CTNM financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.